GHO acquires X-Chem

By The Science Advisory Board staff writers

June 3, 2020 -- Global Healthcare Opportunities (GHO) has acquired X-Chem, a biotechnology company that provides drug discovery services via DNA-encoded library technology.

GHO plans to increase its technology and service proposition following the completion of the acquisition, according to the company.

X-Chem's proprietary DNA-encoded library platform contains over 200 billion small molecules that it can leverage for drug discovery services.

Matt Clark, co-founder of X-Chem and its current senior vice president, will be named its chief executive officer (CEO). Rick Wagner, co-founder and CEO of X-Chem, will resign from the company.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.